Burning Rock Biotech (BNR) Payables (2021 - 2023)

Burning Rock Biotech has reported Payables over the past 3 years, most recently at $2.5 million for Q4 2023.

  • Quarterly results put Payables at $2.5 million for Q4 2023, down 64.98% from a year ago — trailing twelve months through Dec 2023 was $2.5 million (down 64.98% YoY), and the annual figure for FY2023 was $2.5 million, down 66.47%.
  • Payables for Q4 2023 was $2.5 million at Burning Rock Biotech, down from $7.2 million in the prior quarter.
  • Over the last five years, Payables for BNR hit a ceiling of $10.2 million in Q4 2021 and a floor of $2.5 million in Q4 2023.
  • Median Payables over the past 3 years was $7.2 million (2022), compared with a mean of $6.6 million.
  • Biggest five-year swings in Payables: tumbled 30.02% in 2022 and later tumbled 64.98% in 2023.
  • Burning Rock Biotech's Payables stood at $10.2 million in 2021, then plummeted by 30.02% to $7.2 million in 2022, then tumbled by 64.98% to $2.5 million in 2023.
  • The last three reported values for Payables were $2.5 million (Q4 2023), $7.2 million (Q4 2022), and $10.2 million (Q4 2021) per Business Quant data.